Effects of Warm Water on GI System in Laparoscopic Cholecystectomy Patients (LCSS)
Investigation of the Effect of Drinking Warm Water on the Gastrointestinal System Functions of Patients Undergoing Laparoscopic Cholecystectomy
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kahramanmaraş, Turkey
- Necip Fazıl Kısakürek Şehir Hastanesi
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- over 18 years old
- having surgery
Exclusion Criteria:
- not meeting the sampling criteria
- Refused to participate Canceled surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control Groups
Routine treatment and care of patients in the CG was continued.
The onset of bowel sounds and flatus requires the initiation of oral fluid and nutrient intake.
Patients in the CG were evaluated at T0, T1, T2, and T3, and data were recorded on a data collection form.
|
|
|
Experimental: Wather Groups
Patients in the WG were provided warm water at the 2nd postoperative hour on the day of surgery.
Patients in the WG were evaluated at T0, T1, T2, and T3 and data were recorded on a data collection form.
The onset of bowel sounds and flatus requires the initiation of oral fluid and nutrient intake.
No other water or food was provided to patients who had no bowel sounds or flatus other than warm water.
|
Patients in the Warm Water Group (WG) received a warm water drinking intervention post-laparoscopic cholecystectomy.
Before intake, the bed head was elevated to 45°C, and gagging and swallowing reflexes were assessed using an Abeslang to touch the oropharynx.
Nausea indicated a positive reflex.
Two patients with negative reflexes were excluded from WG.
To maintain water temperature, individual insulated cups with thermal features were used, preventing infection transmission.
Water was boiled in a clinic kettle, cooled to 37-38°C, and given to patients to drink within 15 minutes.
Swallowing ability was monitored after the first sip; successful swallowing allowed the patient to continue.
Patients were observed for 15 minutes with an aspirator on standby for aspiration risks.
No complications occurred during the water drinking process in WG.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Descriptive Information Form:
Time Frame: up to 18 weeks
|
The descriptive information form consisted of two parts.
The first part comprised seven open-ended and five multiple-choice questions to determine the patients' descriptive characteristics.
This part of the form was completed by the patients 1 day before surgery.
The second part comprised nine multiple-choice questions aimed at determining the patients' surgical characteristics.
This diagnostic information was provided by the researcher.
|
up to 18 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative Measurement and Evaluation Form:
Time Frame: up to 18 weeks
|
The postoperative measurement and evaluation form included nine open-ended and seven multiple-choice questions designed to determine the vital signs and GI functions of the patients.
Patients were evaluated during the postoperative period and the findings are presented in the relevant sections.
|
up to 18 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Kilis7AralikUNİ
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.